Enteral feeding is compatible with the body’s physiological processes and helps maintain the gut’s functioning, structural integrity, and immune benefits. Early enteral feeding is associated with better outcomes after surgery, even with major procedures involving the abdomen and/or gastrointestinal tract. Early enteral feeding (12 hours after surgery) is associated with fewer viral infections and better nitrogen retention than parenteral feeding. Total parenteral nutrition (TPN) is more expensive compared to enteral nutrition. Therefore, the cost of long-term artificial nutrition using TPN can be a financial burden for patients and their families. Enteral feeding is preferred over parenteral as it is more physiological, simpler, safer, more cost-effective, and less complicated. Also, increased infectious complications are associated with parenteral feeding. Thus, enteral feeding is more widely accepted than parenteral feeding due to its benefits, which is expected to drive the growth of this market.
In its latest publication on Enteral Feeding Devices, Meticulous Research® states that the enteral feeding devices market is expected to grow at a CAGR of 6.5% from 2022 to 2029 to reach $4.72 billion by 2029.
The growth of the enteral feeding devices market is attributed to the growing aging population and the associated increase in the prevalence of chronic diseases, the shift from parenteral nutrition to enteral nutrition, technological advancements in enteral feeding devices, and the growing demand for enteral feeding in home care settings. However, insufficient reimbursements for enteral nutrition are expected to hinder the growth of this market to a certain extent. The growing scope of enteral nutrition in emerging countries is expected to create growth opportunities for market stakeholders, while complications associated with enteral feeding devices are a major challenge for the growth of this market.
Download Free Report Sample Now : https://www.meticulousresearch.com/download-sample-report/cp_id=5244
For efficient analysis, Meticulous Research® has segmented this market by Product (Enteral Feeding Pumps, Enteral Feeding Tubes, Enteral Syringes, Giving Sets/Administration Sets, and Accessories), Age Group (Adults, Pediatrics), Application (Oncology, Gastrointestinal Diseases, Neurological Disorders, Diabetes, Hypermetabolism, and Other Applications), End User (Hospitals, Home Care Settings, and Ambulatory Care Settings), and Geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).
By region, North America is expected to account for the largest share of the enteral feeding devices market in 2022, closely followed by Europe and Asia-Pacific. North America’s large share is attributed to the rising incidence of various disorders and critical illnesses, various initiatives and programs supporting the adoption of enteral nutrition, a well-structured health care system, and standardized reimbursement policies for enteral nutrition. However, Asia-Pacific is slated to register the highest growth rate during the forecast period.
Based on product, the enteral feeding pumps segment is expected to account for the largest share of the enteral feeding devices market in 2022. The segment’s large share is attributed to the rising adoption of enteral feeding pumps due to their advanced features, benefits such as precision, safety, and feasibility in providing enteral nutrition, and advantages over other methods.
Based on application, the oncology segment is expected to register the highest growth rate during the forecast period. The growth of this segment is attributed to the rising number of patients undergoing cancer treatments and thus requiring enteral nutrition to prevent malnourishment and enable better outcomes.
Quick Buy Now: https://www.meticulousresearch.com/Checkout/34890566
The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, and geographical presence on the key players in this market, including Becton, Dickinson and Company (U.S.), Cardinal Health, Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), Avanos Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.), B. Braun Melsungen AG (Germany), Moog Inc. (U.S.), Amsino International Inc. (U.S.), Cook Medical LLC (U.S.), and Applied Medical Technology, Inc. (U.S.).
Key Questions Answered in the Report:
- Which are the high-growth market segments in terms of product, age group, application, end user, and geography?
- What was the historical market size of the global enteral feeding devices market?
- What are the market forecasts and estimates for the period 2022–2029?
- What are the major drivers, restraints, challenges, opportunities, and trends in the enteral feeding devices market?
- Who are the major players in the enteral feeding devices market?
- How is the competitive landscape and who are the market leaders in the enteral feeding devices market?
- What are the recent developments in the enteral feeding devices market?
- What are the various strategies adopted by major players in the enteral feeding devices market?
- What are the geographical trends, and which are the high-growth regions/countries?
Speak to Analyst : https://www.meticulousresearch.com/speak-to-analyst/cp_id=5244
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research